Available Stat

No

Performing Lab

Genomic Services - Molecular Diagnostics

Performed

Batched assay performed once every 1-2 weeks

Methodology

PCR/Fragment analysis and Direct Sequencing

Reported

10-14 days

Additional Information

Somatic calreticulin (CALR) exon 9 mutations have been reported in 70-84% of patients with essential thrombocythemia (ET) or primary myelofibrosis (PMF), without JAK2 or MPL mutations. The risk of thrombosis in patients with CALR-mutated ET was found to be significantly lower than in those with JAK2-mutated ET. These indel frameshift mutations occur in the C-terminus negatively charged domain of the CALR protein and result in a positively charged domain that exhibits cellular localization outside of the endoplasmic reticulum.

Synonyms

  • CALR

Sample Type

Blood and bone marrow aspirates

Collect

Lavender top

Preferred Volume

Blood: 3 mL
Bone marrow aspirates: 1 mL

Minimum Volume

Blood: 1 mL
Bone marrow aspirates: 0.5 mL

Remarks

Do not collect sample in heparin. Keep sample refrigerated for overnight or longer storage.

Stability (from collection to initiation)

Room temperature: 3 days
Refrigerated: 1 week
Frozen at -20C: Unacceptable.

Unacceptable Conditions

Heparinized sample submitted.

Test Code

CALR

Performing Lab

Genomic Services - Molecular Diagnostics

Specimen Preparation

Do not centrifuge. Refrigerate sample but do not freeze. Ship room temperature.

Preferred Volume

Blood: 3 mL
Bone marrow aspirates: 1 mL

Minimum Volume

Blood: 1 mL
Bone marrow aspirates: 0.5 mL

Unacceptable Conditions

Heparinized sample submitted.

Stability (from collection to initiation)

Room temperature: 3 days
Refrigerated: 1 week
Frozen at -20C: Unacceptable.

Reference Interval

Negative

Additional Information

Somatic calreticulin (CALR) exon 9 mutations have been reported in 70-84% of patients with essential thrombocythemia (ET) or primary myelofibrosis (PMF), without JAK2 or MPL mutations. The risk of thrombosis in patients with CALR-mutated ET was found to be significantly lower than in those with JAK2-mutated ET. These indel frameshift mutations occur in the C-terminus negatively charged domain of the CALR protein and result in a positively charged domain that exhibits cellular localization outside of the endoplasmic reticulum.

CPT Codes

81219

LDT or Modified FDA

Yes

Available Stat

No

Test Code

CALR

Performing Lab

Genomic Services - Molecular Diagnostics

Performed

Batched assay performed once every 1-2 weeks

Methodology

PCR/Fragment analysis and Direct Sequencing

Remarks

Do not collect sample in heparin. Keep sample refrigerated for overnight or longer storage.

Collect

Lavender top

Sample Type

Blood and bone marrow aspirates

Preferred Volume

Blood: 3 mL
Bone marrow aspirates: 1 mL

Minimum Volume

Blood: 1 mL
Bone marrow aspirates: 0.5 mL

Unacceptable Conditions

Heparinized sample submitted.

Specimen Preparation

Do not centrifuge. Refrigerate sample but do not freeze. Ship room temperature.

Reference Interval

Negative

Synonyms

  • CALR

Stability (from collection to initiation)

Room temperature: 3 days
Refrigerated: 1 week
Frozen at -20C: Unacceptable.

Reported

10-14 days

Additional Information

Somatic calreticulin (CALR) exon 9 mutations have been reported in 70-84% of patients with essential thrombocythemia (ET) or primary myelofibrosis (PMF), without JAK2 or MPL mutations. The risk of thrombosis in patients with CALR-mutated ET was found to be significantly lower than in those with JAK2-mutated ET. These indel frameshift mutations occur in the C-terminus negatively charged domain of the CALR protein and result in a positively charged domain that exhibits cellular localization outside of the endoplasmic reticulum.

CPT Codes

81219

LDT or Modified FDA

Yes
Ordering

Available Stat

No

Performing Lab

Genomic Services - Molecular Diagnostics

Performed

Batched assay performed once every 1-2 weeks

Methodology

PCR/Fragment analysis and Direct Sequencing

Reported

10-14 days

Additional Information

Somatic calreticulin (CALR) exon 9 mutations have been reported in 70-84% of patients with essential thrombocythemia (ET) or primary myelofibrosis (PMF), without JAK2 or MPL mutations. The risk of thrombosis in patients with CALR-mutated ET was found to be significantly lower than in those with JAK2-mutated ET. These indel frameshift mutations occur in the C-terminus negatively charged domain of the CALR protein and result in a positively charged domain that exhibits cellular localization outside of the endoplasmic reticulum.

Synonyms

  • CALR
Collection

Sample Type

Blood and bone marrow aspirates

Collect

Lavender top

Preferred Volume

Blood: 3 mL
Bone marrow aspirates: 1 mL

Minimum Volume

Blood: 1 mL
Bone marrow aspirates: 0.5 mL

Remarks

Do not collect sample in heparin. Keep sample refrigerated for overnight or longer storage.

Stability (from collection to initiation)

Room temperature: 3 days
Refrigerated: 1 week
Frozen at -20C: Unacceptable.

Unacceptable Conditions

Heparinized sample submitted.
Processing

Test Code

CALR

Performing Lab

Genomic Services - Molecular Diagnostics

Specimen Preparation

Do not centrifuge. Refrigerate sample but do not freeze. Ship room temperature.

Preferred Volume

Blood: 3 mL
Bone marrow aspirates: 1 mL

Minimum Volume

Blood: 1 mL
Bone marrow aspirates: 0.5 mL

Unacceptable Conditions

Heparinized sample submitted.

Stability (from collection to initiation)

Room temperature: 3 days
Refrigerated: 1 week
Frozen at -20C: Unacceptable.
Result Interpretation

Reference Interval

Negative

Additional Information

Somatic calreticulin (CALR) exon 9 mutations have been reported in 70-84% of patients with essential thrombocythemia (ET) or primary myelofibrosis (PMF), without JAK2 or MPL mutations. The risk of thrombosis in patients with CALR-mutated ET was found to be significantly lower than in those with JAK2-mutated ET. These indel frameshift mutations occur in the C-terminus negatively charged domain of the CALR protein and result in a positively charged domain that exhibits cellular localization outside of the endoplasmic reticulum.
Administrative

CPT Codes

81219

LDT or Modified FDA

Yes
Complete View

Available Stat

No

Test Code

CALR

Performing Lab

Genomic Services - Molecular Diagnostics

Performed

Batched assay performed once every 1-2 weeks

Methodology

PCR/Fragment analysis and Direct Sequencing

Remarks

Do not collect sample in heparin. Keep sample refrigerated for overnight or longer storage.

Collect

Lavender top

Sample Type

Blood and bone marrow aspirates

Preferred Volume

Blood: 3 mL
Bone marrow aspirates: 1 mL

Minimum Volume

Blood: 1 mL
Bone marrow aspirates: 0.5 mL

Unacceptable Conditions

Heparinized sample submitted.

Specimen Preparation

Do not centrifuge. Refrigerate sample but do not freeze. Ship room temperature.

Reference Interval

Negative

Synonyms

  • CALR

Stability (from collection to initiation)

Room temperature: 3 days
Refrigerated: 1 week
Frozen at -20C: Unacceptable.

Reported

10-14 days

Additional Information

Somatic calreticulin (CALR) exon 9 mutations have been reported in 70-84% of patients with essential thrombocythemia (ET) or primary myelofibrosis (PMF), without JAK2 or MPL mutations. The risk of thrombosis in patients with CALR-mutated ET was found to be significantly lower than in those with JAK2-mutated ET. These indel frameshift mutations occur in the C-terminus negatively charged domain of the CALR protein and result in a positively charged domain that exhibits cellular localization outside of the endoplasmic reticulum.

CPT Codes

81219

LDT or Modified FDA

Yes